Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Total Liabilities (2016 - 2025)

OptimizeRx (OPRX) has disclosed Total Liabilities for 16 consecutive years, with $48.6 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 10.24% to $48.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.6 million through Dec 2025, down 10.24% year-over-year, with the annual reading at $48.6 million for FY2025, 10.24% down from the prior year.
  • Total Liabilities hit $48.6 million in Q4 2025 for OptimizeRx, up from $48.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $56.8 million in Q4 2023 to a low of $5.5 million in Q2 2023.
  • Historically, Total Liabilities has averaged $27.3 million across 5 years, with a median of $9.1 million in 2021.
  • Biggest five-year swings in Total Liabilities: crashed 54.52% in 2021 and later skyrocketed 841.25% in 2024.
  • Year by year, Total Liabilities stood at $9.6 million in 2021, then dropped by 11.09% to $8.5 million in 2022, then skyrocketed by 565.32% to $56.8 million in 2023, then fell by 4.67% to $54.2 million in 2024, then decreased by 10.24% to $48.6 million in 2025.
  • Business Quant data shows Total Liabilities for OPRX at $48.6 million in Q4 2025, $48.1 million in Q3 2025, and $50.0 million in Q2 2025.